M., Friedman, A., Manfredi, M., & Jones, R
This systematic review analysed 17 studies with 992 MIS-C patients from low-income and middle-income countries (LMICs) and developed countries (France, the UK, Italy, Spain, Chile and the US CDC data)
Patients who experience rapid dose escalation may be more prone to fatigue and gastrointestinal symptoms
Our results also indicate the potential involvement of the -catenin signaling pathway by showing the impact of Ex-4 on the expression of nuclear transcription factors SREBP-1, a key regulator of lipid metabolism in the liver 72 , and TCF4, a central transcription factor in the -catenin pathway, when -catenin is silenced
Specific unbinding forces between mutated human P-selectin glycoprotein ligand-1 and viral protein-1 measured using force spectroscopy